Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 478 participants.
Also called NCT01453582
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 478 participants
- Sponsor
- Shanghai Greenvalley Pharmaceutical Co., Ltd.
- Registry
-
NCT01453582
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01453582. Randomized; double masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2014-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris
- Condition
- Stable Angina Pectoris
- Intervention (Drug)
- Total Flavonoids of Propolis dropping pill
- Intervention (Drug)
- total Flavonoids of Propolis dropping pill
- Lead sponsor
- Shanghai Greenvalley Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct01453582- Content hash
6f1d715339a7340640872ea381efebeb16e445cf55618d22a7b0f81935527a4b